We not only have the expertise to develop phase appropriate drug formulations for stability, pre-clinical and clinical assessment, but we also have the technology and team to provide innovative solutions for challenging molecules, that will leverage long term value.
We can provide you formulation development options with our rapid screening service. Our wealth of experience in drug delivery systems and developing formulations will deliver formulations for APIs in each class of the Biopharmaceutics Classification System (BCS). We also offer a platform of Enabling Technologies for overcoming API permeability and solubility issues.
We also develop and validate analytical methods to support pharmaceutical product development from early development (chemical and physical stability, formulation-packaging compatibility) to manufacture (QC release testing and ICH stability testing).
Alongside our wealth of practical analytical and development experience, we combine our specialist expertise in advanced characterisation and drug delivery systems. This unique combination assists our screening approaches and helps optimise and trouble shoot development, ensuring your drug product will move quickly and efficiently to clinic.